Recent advances in antibody-drug conjugates (ADCs) demand more nuanced classifications of the full spectrum of HER2. However, reproducibility of manual HER2-low and -ultralow scoring is challenged due to a scoring classification not feasible for the human eye. A better way to score HER2 is required.

Introducing our new, fully automated HER2 algorithm:
Enabling precise quantification of expression across the complete spectrum.

Download now